Biomind Labs Inc (NEO:BMND) — Stock Price

CA$0.69 CAD
▲ 16.95% today

Biomind Labs Inc (NEO:BMND) is currently trading at CA$0.69 CAD, up 16.95% today. Over the past 52 weeks, shares have ranged between CA$0.01 and CA$0.69. This page tracks Biomind Labs Inc's live share price on the NEO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BMND company net worth.

Biomind Labs Inc (BMND) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Biomind Labs Inc's daily closing share price and trading volume on the NEO exchange over the past year, giving a clear view of recent price momentum and liquidity.

Biomind Labs Inc Income Statement — Revenue, Profit & Earnings by Year

Biomind Labs Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CA$0.00 CA$0.00 CA$0.00 CA$0.00 CA$0.00
Cost of Revenue
Gross Profit
Research & Development CA$0.00 CA$16.06K CA$306.95K CA$574.44K CA$570.95K
SG&A CA$648.54K CA$171.51K CA$669.33K CA$2.09 Million CA$2.83 Million
Total Operating Expenses CA$846.60K CA$404.45K CA$991.43K CA$2.93 Million CA$3.43 Million
Operating Income CA$-846.60K CA$-404.45K CA$-991.43K CA$-2.93 Million CA$-3.43 Million
EBITDA CA$-2.94 Million CA$-4.30 Million
EBIT CA$-3.43 Million
Interest Expense CA$68.71K CA$32.65K CA$161.39K CA$1.36K CA$3.71K
Income Before Tax CA$-850.41K CA$-260.48K CA$-1.19 Million CA$-2.99 Million CA$-4.33 Million
Income Tax Expense
Net Income CA$-850.41K CA$-260.48K CA$-1.19 Million CA$-2.99 Million CA$-4.33 Million

Biomind Labs Inc Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Biomind Labs Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CA$36.00 CA$41.16K CA$74.20K CA$89.06K CA$2.53 Million
Total Current Assets CA$36.00 CA$21.10K CA$45.22K CA$44.93K CA$2.44 Million
Cash & Equivalents
Short-term Investments
Net Receivables
Inventory
Property, Plant & Equipment CA$88.37K
Goodwill
Total Liabilities CA$1.74 Million CA$1.34 Million CA$1.51 Million CA$336.72K CA$334.95K
Total Current Liabilities CA$1.74 Million CA$1.34 Million CA$1.51 Million CA$336.72K CA$324.69K
Long-term Debt
Net Debt CA$728.45K CA$670.53K CA$715.06K
Total Stockholder Equity CA$-1.74 Million CA$-1.30 Million CA$-1.43 Million CA$-247.66K CA$2.19 Million
Retained Earnings CA$-15.74 Million CA$-14.88 Million CA$-14.62 Million CA$-13.43 Million CA$-10.45 Million

Biomind Labs Inc Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Biomind Labs Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CA$-67.55K CA$-354.43K CA$-765.93K CA$-2.15 Million CA$-2.12 Million
Capital Expenditures CA$0.00 CA$0.00 CA$0.00 CA$0.00 CA$44.59K
Free Cash Flow CA$-67.55K CA$-354.43K CA$-765.93K CA$-2.15 Million CA$-2.17 Million
Investing Cash Flow CA$-44.34K
Financing Cash Flow CA$86.34K CA$302.25K CA$762.45K CA$-38.52K CA$4.47 Million
Dividends Paid
Stock-Based Compensation CA$422.23K CA$0.00 CA$7.50K CA$553.62K CA$1.38 Million
Depreciation CA$2.23K CA$8.92K CA$15.15K CA$44.24K CA$28.32K
Change in Cash CA$18.79K CA$-52.18K CA$-3.48K CA$-2.19 Million CA$2.30 Million

Biomind Labs Inc Earnings History — EPS Actual vs. Analyst Estimates

Track Biomind Labs Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for Biomind Labs Inc.